Experienced. Resourceful. Effective.

Month: April 2013

Clinical Trials Start for GL-ONC1 Drug That May Benefit Mesothelioma Patients

On Behalf of VanNess & VanNess, P.A. | Apr 30, 2013 | Clinical Trials

Mesothelioma patients may benefit from the results of the clinical trials being conducted at Memorial Sloan-Kettering Cancer Center in New York. Recently, researchers have tested a Wilms Tumor-1 (WT1) vaccine to see if it delays or prevents malignant pleural...

First week of April designated “National Asbestos Awareness Week”

On Behalf of VanNess & VanNess, P.A. | Apr 7, 2013 | Treatment Options

The U.S. Senate unanimously passed Senate resolution 66 designating the first week of April 2013 as "National Asbestos Awareness Week." Asbestos is known to cause lung cancer and mesothelioma by breathing in asbestos fibers that become lodged in the lung or lining of...